Abstract-A glycoprotein, Aloctin A, which was isolated from Aloe arborescens Mill, markedly inhibits adjuvant arthritis in rats and carrageenin induced edema in rats.
I n the previous paper, we demonstrated that Aloctin A (Alo A) could inhibit the growth of methylcholanthrene induced fibrosarcoma (Meth A) in vivo but not in vitro (1) . The mechanism of this growth in hibition seemed to be host-mediated. Alo A which is isolated from leaves of Aloe arborescens Mill has many biological activities including mitogenic activity for lymphocytes and cytoagglutination (2, 3) . Since Aloe arborescens Mill has been known to be used as an anti-inflammatory agent in folklore medicine, we examine in the present paper whether Alo A affects adjuvant arthritis in rats by using the method of Newbould (4) and determine whether Alo A affects car rageenin-induced edema in rats by using the method of Winter et al. (5) .
MATERIALS AND METHODS

Agents used
Indomethacin (Nippon Merck-Banyu Co., Ltd.), prednisolone (Shionogi & Co., Ltd.), carrageenin (Marine Colloid Co., Ltd., USA), liquid paraffin (Merck, Germany) and heat killed Mycobacterium butyricum (Difco) were used. Preparation of Alo A was according to a method previously described (2).
Animals
Sprague-Dawley rats were obtained from Charles River Japan Inc. Kanagawa, Japan. All rats were female and had weights of about 200 g. Compounds to be tested were administered orally or intraperitoneally, once daily for 15 days, starting from 1 day before injection of the phlogistic agent into the foot. In a preliminary investigation, oral administration of Alo A did not affect adjuvant arthritis at the doses tested in this experiment; conse quently, Alo A suspended in 0.9% NaCI solution at proper concentrations was admin istered intraperitoneally throughout this experiment. Indomethacin or prednisolone in aqueous suspension was administered by *On leave from The Koriyama Institute of Medical Immunology, Koriyama 963, Japan "*To whom all correspondence should be addressed .
gastric gavage.
Controls received adjuvant, but no drug.
Body weight and foot volume were recorded nearly every day.
b. Edema formation and compound treat ment:
Hind paw edema was induced by a s.c. injection of 0.05 ml of 1 % carrageenin solution in 0.9% NaCl into the right hind foot pads of rats. Ale A suspended in 0.9% NaCl solution was intraperitoneally adminis tered 30 min prior to the injection of the phlogistic agent. Indomethacin in aqueous suspension was administered by gastric gavage.
The volume measurements were made before and at 1, 3, 4 and 5 hr after the injection of the phlogistic agent.
c. Volume measurement and calculation of % inhibition: Hind raw volume was measured by the water displacement method (6) .
The effects of compounds were expressed in terms of the percentage inhibition of swelling voli.ime in the treated group as compared with the control.
The percentage inhibition was calculated as follows % inhibition-(1 a-x 1 X 100 b-y where a is the mean hind paw volume of compound treated rats at the fixed times after inciter injection, b is the mean hind paw volume of control rats at the fixed times after inciter injection, x is the mean hind paw volume of compound treated rats before inciter injection, and y is the mean hind paw volume of control rats before inciter injection. Table 1 shows data obtained on the 14th day after adjuvant injection, immediately after the end of treatment, and on the 21st day, 8 days after withdrawal of the compound. Treatment with Alo A at all doses tested effectively suppressed the swelling in the injected foot and in the secondary lesion, and the optimal dose was 5 mg/kg/day. Anti arthritis activity of Ale A given i.p. seems to Table 1 . Effect cf Aloctin A on arthritis induced in rats by mycobacterial adjuvant Table   2 . Effect of Aloctin A on swelling of rat hind paw induced by carrageenin be higher than that of indomethacin given p.o., and its activity was almost equal lo that of prednisolone given p.o. Body weight loss of rats treated with Alo A was not observed and at the optimal dose for anti-arthritis (5 mg/kg/day), Alo A-treated rats obviously gained body weight. Throughout this experi ment, no recognizable side reactions of Alo A were observed.
RESULTS
Effect of Alo
Since an anti-arthritic agent, N-(2 carhoxyphenyl)-4-chloroanthranilic acid dis odium salt, which has immunoenhancing activity, as opposed to immunosuppressive activity, has no anti-inflammatory activity (7), it is of interest to know whether Ale A possesses an anti-inflammatory activity or not. Table 2 shows the results of an experi ment designed to examine this point. When Alo A was given intraperitoneally 30 min before injection of carrageenin, a marked inhibition of edema was observed 3 hr after injection of carrageenin.
The effect of Alo A was dose-dependent up to 10 mg/kg, the highest dose tested.
DISCUSSION
The present experiments showed that Alo A inhibits adjuvant arthritis in rats and also 
